Physician-Modified Endovascular Grafts for Zone-2 Thoracic Endovascular Aortic Repair

Abstract

Objective This study aims to describe our technique and early experience with physician-modified endovascular grafts (PMEGs) for aortic arch diseases in zone 2. We used a total endovascular technique based on a single fenestrated endograft to preserve left subclavian artery (LSA) patency.

Methods From December 2019 to August 2020, six consecutive patients with a variety of thoracic aortic diseases were treated with handmade fenestrated thoracic aortic grafts: four aortic dissections, one penetrating aortic ulcer, and one intramural hematoma. The planning, endograft modification, surgical technique, and follow-up of the patients were described. We evaluated immediate technical success and after 30 days, the LSA patency, Type-1 endoleak, and postoperative complications.

Results Thoracic endovascular aortic repair (TEVAR) was performed for zone 2 in all cases. Immediate technical success, defined as successful alignment of the LSA with a covered stent and no Type-1 endoleak, was achieved in all cases. Patients had a 30-day follow-up computed tomography, which demonstrated LSA patency and no Type-I endoleaks. To date, no strokes, left arm ischemia, paraplegia, or conversions to open surgery have been reported; one patient operated for acute Type B dissection died during the early follow-up.

Conclusion TEVAR for zone 2 with a PMEG to maintain LSA patency achieved technical success and early durability. It is expected that with longer follow-up and a larger number of cases, these results will be confirmed.

Keywords

aortic arch - endovascular - TEVAR - fenestration - physician-modified endograft

Publikationsverlauf

Eingereicht: 01. Oktober 2020

Angenommen: 02. Juli 2021

Artikel online veröffentlicht:
31. Mai 2022

• References

• 1 Gloviczki P. ESVS Volodos lecture: innovations and the Hippocratic oath. Eur J Vasc Endovasc Surg 2018; 55 (05) 605-613
• 2 Gutsche JT, Cheung AT, McGarvey ML. et al. Risk factors for perioperative stroke after thoracic endovascular aortic repair. Ann Thorac Surg 2007; 84 (04) 1195-1200 , discussion 1200
• 3 Delafontaine JL, Hu B, Tan TW. et al. Outcome comparison of TEVAR with and without left subclavian artery revascularization from analysis of nationwide inpatient sample database. Ann Vasc Surg 2019; 58: 174-179
• 4 Bradshaw RJ, Ahanchi SS, Powell O. et al. Left subclavian artery revascularization in zone 2 thoracic endovascular aortic repair is associated with lower stroke risk across all aortic diseases. J Vasc Surg 2017; 65 (05) 1270-1279
• 5 Matsumura JS, Lee WA, Mitchell RS. et al; Society for Vascular Surgery. The Society for Vascular Surgery practice guidelines: management of the left subclavian artery with thoracic endovascular aortic repair. J Vasc Surg 2009; 50 (05) 1155-1158
• 6 Rizvi AZ, Murad MH, Fairman RM, Erwin PJ, Montori VM. The effect of left subclavian artery coverage on morbidity and mortality in patients undergoing endovascular thoracic aortic interventions: a systematic review and meta-analysis. J Vasc Surg 2009; 50 (05) 1159-1169
• 7 Saouti N, Hindori V, Morshuis WJ, Heijmen RH. Left subclavian artery revascularization as part of thoracic stent grafting. Eur J Cardiothorac Surg 2015; 47 (01) 120-125 , discussion 125
• 8 Domenig CM, Linni K, Mader N, Kretschmer G, Magometschnigg H, Hölzenbein TJ. Subclavian to carotid artery transposition: medial versus lateral approach. Eur J Vasc Endovasc Surg 2008; 35 (05) 551-557
• 9 XiaoHui M, Li W, Wei G. et al. Comparison of supra-arch in situ fenestration and chimney techniques for aortic dissection involving the left subclavian artery. Vascular 2019; 27 (02) 153-160
• 10 Tsilimparis N, Law Y, Rohlffs F, Spanos K, Debus ES, Kölbel T. Fenestrated endovascular repair for diseases involving the aortic arch. J Vasc Surg 2020; 71 (05) 1464-1471
• 11 Starnes BW. Physician-modified endovascular grafts for the treatment of elective, symptomatic, or ruptured juxtarenal aortic aneurysms. J Vasc Surg 2012; 56 (03) 601-607
• 12 Canaud L, Morishita K, Gandet T. et al. Homemade fenestrated stent-graft for thoracic endovascular aortic repair of zone 2 aortic lesions. J Thorac Cardiovasc Surg 2018; 155 (02) 488-493
• 13 Zhu J, Zhao L, Dai X. et al. Fenestrated thoracic endovascular aortic repair using physician modified stent grafts for acute Type B aortic dissection with unfavourable landing zone. Eur J Vasc Endovasc Surg 2018; 55 (02) 170-176
• 14 Zamor KC, Eskandari MK, Rodriguez HE, Ho KJ, Morasch MD, Hoel AW. Outcomes of thoracic endovascular aortic repair and subclavian revascularization techniques. J Am Coll Surg 2015; 221 (01) 93-100
• 15 Rehman SM, Vecht JA, Perera R. et al. How to manage the left subclavian artery during endovascular stenting for thoracic aortic dissection? An assessment of the evidence. Ann Vasc Surg 2010; 24 (07) 956-965
• 16 Hogendoorn W, Schlösser FJ, Moll FL, Sumpio BE, Muhs BE. Thoracic endovascular aortic repair with the chimney graft technique. J Vasc Surg 2013; 58 (02) 502-511
• 17 Ding H, Liu Y, Xie N. et al. Outcomes of chimney technique for preservation of the left subclavian artery in Type B aortic dissection. Eur J Vasc Endovasc Surg 2019; 57 (03) 374-381
• 18 Roselli EE, Arko III FR, Thompson MM. Valiant Mona LSA Trial Investigators. Results of the Valiant Mona LSA early feasibility study for descending thoracic aneurysms. J Vasc Surg 2015; 62 (06) 1465-71.e3
• 19 Patel HJ, Dake MD, Bavaria JE. et al. Branched endovascular therapy of the distal aortic arch: preliminary results of the feasibility multicenter trial of the gore thoracic branch endoprosthesis. Ann Thorac Surg 2016; 102 (04) 1190-1198
• 20 Kölbel T, Rohlffs F, Wipper S, Carpenter SW, Debus ES, Tsilimparis N. Carbon dioxide flushing technique to prevent cerebral arterial air embolism and stroke during TEVAR. J Endovasc Ther 2016; 23 (02) 393-395
• 21 Sweet MP. Anatomic features of the distal aortic arch that influence endovascular aneurysm repair. J Vasc Surg 2016; 64 (04) 891-895
• 22 Georgiadis GS, van Herwaarden JA, Antoniou GA. et al. Systematic review of off-the-shelf or physician-modified fenestrated and branched endografts. J Endovasc Ther 2016; 23 (01) 98-109
• 23 Chassin-Trubert L, Mandelli M, Ozdemir BA, Alric P, Gandet T, Canaud L. Midterm follow-up of fenestrated and scalloped physician-modified endovascular grafts for zone 2 TEVAR. J Endovasc Ther 2020; 27 (03) 377-384
• 24 Oderich GS. Commentary: physician-modified vs off-the-shelf fenestrated and branched endografts: is this a fair comparison?. J Endovasc Ther 2016; 23 (01) 110-114